Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib

Abstract

Background. Small molecules that inhibit V600 mutated BRAF protein, such as vemurafenib and dabrafenib, are effective in treatment of metastatic melanoma.

Keywords

• dabrafenib
• electrochemotherapy
• melanoma
• braf inhibitors
• bleomycin